Hyperhomocysteinemia is a risk factor for postoperative ischemia in adult patients with moyamoya disease
- 27 January 2021
- journal article
- research article
- Published by Springer Nature in Neurosurgical Review
- Vol. 44 (5) , 2913-2921
Abstract
Growing evidence has suggested that hyperhomocysteinemia (HHcy) is a risk factor for cerebral infarction. However, the effect of HHcy on postoperative cerebral ischemia is still unclear. We aim to investigate the relationship between HHcy and postoperative ischemia of adult patients with moyamoya disease (MMD). A total of 138 adult patients with MMD were prospectively recruited from July 1 to December 31, 2019. After excluding 14 patients accepting conservative therapy, all 124 patients who underwent surgical treatment were enrolled. Patients were grouped according to postoperative ischemia and HHcy presentation, respectively. Clinical data and laboratory examinations were compared by statistical analyses. Potential risk factors were evaluated by univariate and multivariate logistic regression analysis. Comparing to the normal, patients with postoperative ischemia were higher in serum homocysteine (Hcy) level (P = 0.039) and HHcy ratio (P = 0.035). Furthermore, HHcy was more common in males (P = 0.007) than females. Logistic analysis results showed that HHcy (OR 5.234, 95% CI 1.127–24.315; P = 0.035) was an independent risk factor. HHcy was significantly associated with postoperative ischemia in MMD patients. Our study found that HHcy was correlated to the risk of postoperative ischemia. HHcy can be used as an indicator and a potential therapeutic target for postoperative ischemia in adult patients with MMD. URL: http://www.chictr.org. Unique identifier: ChiCTR2000031412.Keywords
This publication has 44 references indexed in Scilit:
- Guidelines for Diagnosis and Treatment of Moyamoya Disease (Spontaneous Occlusion of the Circle of Willis)Neurologia medico-chirurgica, 2012
- Neurosurgical Advances in the Treatment of Moyamoya DiseaseStroke, 2011
- Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trialsThe Lancet, 2011
- What is the expert's option on antiplatelet therapy in moyamoya disease? Results of a worldwide SurveyEuropean Journal of Neurology, 2011
- Homocysteine–NMDA receptor‐mediated activation of extracellular signal‐regulated kinase leads to neuronal cell deathJournal of Neurochemistry, 2009
- Moyamoya Disease and Moyamoya SyndromeNew England Journal of Medicine, 2009
- Prevalence and Clinicoepidemiological Features of Moyamoya Disease in JapanStroke, 2008
- Homocysteine and strokeCurrent Opinion in Neurology, 2001
- Homocysteine, Coagulation, Platelet Function, and ThrombosisSeminars in Thrombosis and Hemostasis, 2000
- Cerebrovascular "Moyamoya" DiseaseArchives of Neurology, 1969